07:50 AM EDT, 03/12/2026 (MT Newswires) -- Indivior Pharmaceuticals ( INDV ) said Thursday it plans a $400 million private offering of convertible senior unsecured notes due March 15, 2031.

The company expects to grant the initial purchasers a 30-day option to buy up to an additional $60 million of the notes.

Indivior said it plans to use the net proceeds to help repay borrowings under and terminate the note purchase agreement that governs its term loan and revolving credit facility, among other things.

The company's shares were down 5.3% in premarket activity.